The Treatment of a Novel Epidermal Growth Factor Receptor (EGFR)-GRB2 Genetic Mutation Using Osimertinib in Metastatic Non-Small Cell Lung Cancer

Mutations in the epidermal growth factor receptor (EGFR) have been implicated in nearly one-third of non-small-cell lung cancers. For patients harboring non-traditional mutations, genomic and transcriptomic sequencing can help direct treatment. As cancer genomics evolves, novel driver mutations cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanathan, Siddharth, Shen, Nathan, Kestin, Larry, Balaraman, Savitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208280/
https://www.ncbi.nlm.nih.gov/pubmed/37234142
http://dx.doi.org/10.7759/cureus.38059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208280/
https://www.ncbi.nlm.nih.gov/pubmed/37234142
http://dx.doi.org/10.7759/cureus.38059

Ejemplares similares